Stephen Patek
Director, Algorithm Engineering; Therapeutics, Diagnostics, and Insights (TDI)
- Role
- Director, Algorithm Engineering Therapeutics, Diagnostics, and Insights (Tdi) at Dexcom
- Location
- Charlottesville, VA, US
- LinkedIn followers
- 500 followers
About Stephen Patek
Creative and engaged R&D leaderCurrent Role: Director, Algorithm Engineering; Therapeutics Diagnostics and Insights (TDI)Claims to Fame:(1) co-inventor of the artificial pancreas algorithm embedded in Control-IQ, improving the lives of people with type 1 diabetes;(2) co-founder and VP R&D: TypeZero Technologies (acquired by Dexcom);(3) 15 US patents (more worldwide & more pending);(4) ex full Professor U. Virginia SEAS (100s of students & publications, millions in grant dollars)Technical Expertise:(1) model-based signal processing and control,(2) stochastic modeling & simulation,(3) inverse methods,(4) stochastic optimization,(5) Markov decision processes & stochastic games,(6) AI/ML & reinforcement learning
Experience
Director, Algorithm Engineering Therapeutics, Diagnostics, and Insights (Tdi)
Dec 2023 — Present · Charlottesville, VA, US
Education
Massachusetts Institute of Technology
Doctor of Philosophy (Ph.D.), EECS (Systems)
1994 — 1997
Massachusetts Institute of Technology
Master’s Degree, EECS
1991 — 1994
University of Tennessee, Knoxville
BS, Electrical Engineering
1985 — 1991
Skills
- Data Analysis
- Program Management
- Systems Engineering
- Research
- Matlab
- Biomedical Engineering
- Simulations
- Mathematical Modeling
- Latex
- Operations Research
- Machine Learning
- Algorithms
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.